𝔖 Bobbio Scriptorium
✦   LIBER   ✦

A new continuous epitope of hepatitis A virus

✍ Scribed by Bosch, Albert; González-Dankaart, Juan F.; Haro, Isabel; Gajardo, Rodrigo; Pérez, José A.; Pintó, Rosa M.

Publisher
John Wiley and Sons
Year
1998
Tongue
English
Weight
250 KB
Volume
54
Category
Article
ISSN
0146-6615

No coin nor oath required. For personal study only.

✦ Synopsis

A new continuous epitope of hepatitis A virus (HAV) was defined in the VP3 protein. Convalescent sera recognised the synthetic peptide 3110-3121 (FWRGDLVFDFQV). The replacement of the arginine, glycine, or aspartic acid at positions 112, 113, or 114, respectively by other aminoacids induced the loss of synthetic peptide recognition by human convalescent sera, thereby confirming the presence of an epitope in the original VP3(110-121) sequence. Shorter VP3 peptides such as VP3(110-119), VP3(110-117), and VP3(110-116) and a tandem repeat of VP3(111-116) failed to react with convalescent sera, indicating the importance of the entire peptide in the epitope structure. The maximum inhibition of human convalescent binding to HAV by the VP3(110-121) peptide was around 60%, and 50% inhibition was achieved at a peptide concentration of 2.3-2.4 µg/ml. Antibodies generated by this peptide bound to intact HAV and neutralised its infectivity. Antipeptide antibodies inhibited convalescent serum binding to HAV. Monoclonal antibodies H7C27 and MAK-4E7 inhibited completely binding of the antipeptide antibodies to HAV.

📜 SIMILAR VOLUMES

A novel CD4+ T-helper lymphocyte epitope
A novel CD4+ T-helper lymphocyte epitope in the VP3 protein of hepatitis A virus
✍ Glòria Sánchez; Rosa M. Pintó; Albert Bosch 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 328 KB

## Abstract Prediction analysis of T~H~‐cell epitopes in the VP3 capsid protein of the hepatitis A virus (HAV) revealed the occurrence of a putative T~H~ epitope in the 102–121 region complying with all the algorithms tested. To confirm these predictions, spleen T lymphocytes obtained from BALB/c m

Identification of a dominant immunogenic
Identification of a dominant immunogenic epitope of the nucleocapsid (HBc) of the hepatitis B virus
✍ J. A. Waters; T. P. Jowett; H. C. Thomas 📂 Article 📅 1986 🏛 John Wiley and Sons 🌐 English ⚖ 467 KB

Four monoclonal antibodies to hepatitis B core antigen are described. The antibodies bind to the same or a very closely related epitope. Antibodies to this dominant epitope are present in the sera of patients with either acute or chronic hepatitis B virus (HBV) infection. A high percentage of inhibi

Hepatitis A—New information on an old vi
Hepatitis A—New information on an old virus
✍ Chris J. Dickinson 📂 Article 📅 1992 🏛 John Wiley and Sons 🌐 English ⚖ 408 KB

Clinicians have been trained to use statistics to identify differences and to reject apparent differences that may have occurred by chance. The objective of studies such as that by Ramond et al. is not to prove that the groups of patients are different at randomization but that they are similar. Sim

Hepatitis A: New information on an old v
Hepatitis A: New information on an old virus
✍ Chris J. Dickinson 📂 Article 📅 1992 🏛 John Wiley and Sons 🌐 English ⚖ 367 KB

HEPATOLOGY Elsewhere 973 6 mo of the study. Furthermore, six study patients treated with ursodeoxycholic acid failed therapy, indicating that not all PBC patients treated with ursodeoxycholic acid therapy respond. Of equal importance, no patient in either group was noted to have a complete clinical,